According to NeuroMetrix, Quell is a wearable intensive nerve stimulation device that stimulates sensory nerves in the upper calf sending neural pulses to the brain.
The first improvement over Lantus, according to Hobbs, is simply the length of time the insulin lasts. While Lantus lasts up to 24 hours per dose “with no pronounced peak,” Tresiba lasts considerably longer.
For Gina’s second transplant (two years after the failure of the first) researchers at City of Hope added a component of treatment called anti-thymoglobbulin induction, or ATG, which is designed to keep the body’s immune system from harming the new islet cells.
One issue with using fear to associate the consumption of sugary beverages with disease is that the behavior becomes stigmatized, and a portion of the population then blames the victim for their behavior. This will tend to happen even if a person already has the condition.
Faustman says that her work has raised the ire of some scientists and organizations for two reasons: It runs counter to the prevailing research emphasis to either prevent type 1 diabetes, or reverse it in people who have been recently diagnosed with diabetes and, at the time, ran into a stiff political headwind from embryonic stem cell researchers.
Is the best way to beat type 1 diabetes to simply stop it before it starts? That’s a question being tackled in new clinical trial that proposes to prevent diabetes in those prone to developing it. “Often times, the best answer is the simple answer,” says Ezio Bonifacio, Ph.D., from the Center for Regenerative Therapies, in Dresden, who led a team of researchers to develop a vaccine to prevent type 1 diabetes. The vaccine has ended up being insulin itself.
The penny-sized patch is embedded with more than one hundred tiny needles, each about the width and length of an eyelash. Those needles in turn are loaded with microscopic storage units containing insulin and glucose-sensing enzymes that trigger a release of insulin when blood sugar levels go past a certain level.
A yearlong clinical trial in more than a dozen countries reveals that once-a-week-Trulicity, used in conjunction with short acting insulin, not only improved blood sugar control for subjects with type 2 diabetes, but also curbed hypoglycemia compared to a standard treatment and reduced weight in trial subjects.
Scientists have successfully reversed type 1 diabetes in mice by using adult stem cells and cell surface molecular engineering to reduce the destruction of insulin-producing islet cells.
The key to the breakthrough was introducing adult stem cells...
Researchers with the Janssen Pharmaceutical Companies of Johnson & Johnson recently announced a plan to prevent type 1 diabetes by intercepting the disease in its earliest stages and stopping its development before the onset of symptoms.